1. Neuroprotective effect of combined use of nicotine and celecoxib by inhibiting neuroinflammation in ischemic rats
- Author
-
Shuqi Wu, Yafu Yin, Yufei Ma, Jinyu Gou, Sheng Liang, Zhiyi Ye, Weiwei Cheng, and Hui Wang
- Subjects
Male ,Nicotine ,Side effect ,medicine.medical_treatment ,Morris water navigation task ,Receptors, Nicotinic ,Pharmacology ,Neuroprotection ,Brain Ischemia ,Rats, Sprague-Dawley ,Cognition ,In vivo ,medicine ,Animals ,Nicotinic Agonists ,Maze Learning ,Saline ,Neuroinflammation ,Brain Chemistry ,Cyclooxygenase 2 Inhibitors ,Endothelin-1 ,business.industry ,General Neuroscience ,Calcium-Binding Proteins ,Microfilament Proteins ,Drug Synergism ,X-Ray Microtomography ,Rats ,Neuroprotective Agents ,Celecoxib ,Neuroinflammatory Diseases ,Cytokines ,Drug Therapy, Combination ,business ,medicine.drug - Abstract
Introduction The contribution of neuroinflammation in cognitive impairment is increasingly recognized. Non-steroidal anti-inflammatory drugs had been proven that it could improve cognitive impairment in large dose but with more side effect, which limited the application. The main objective of this study was to investigate whether the combined use of nicotine and celecoxib could obtain synergistic neuroprotective effect in ischemic rats. Methods Twenty adult Sprague-Dawley (SD) rats underwent ischemic model surgery by injecting endothelin-1 into the left thalamus, which were classified into four groups with different interventions: nicotine (1.5 mg/kg/d), celecoxib (15 mg/kg/d), nicotine (1.5 mg/kg/d) +celecoxib (15 mg/kg/d), or saline after surgery. The other five SD rats also underwent same surgery by injecting saline instead of endothelin-1, as the control group. Morris water maze (MWM) test was adopted to assess the cognition. Micro PET/CT with 2-[18F]-A-85380 were performed for α4β2-nAChRs detection in vivo. Western blot, real-time PCR and immunohistochemical staining were adopted to detect the expression of α4β2-nAChRs and inflammatory factors which included TNF-α, IL-1β, IL-6 in brain tissue. Microglial activation in the brain was monitored by immunofluorescence with IBA1 staining. Results The MWM test showed rats given with nicotine or celecoxib alone showed much better memory than rats with saline, no difference was observed between nicotine and celecoxib. The rat memory was recovered most significant when the nicotine and celecoxib were combined (p Conclusions The study revealed the combined use of nicotine and celecoxib may improve the cognitive function in ischemic rats, with a better effect than either alone. Both nicotine and celecoxib can inhibit inflammation, but through different mechanisms: nicotine can activate α4β2-nAChRs while celecoxib is cyclooxygenase-2 inhibitor. Our findings suggest the combined application of two drugs with different anti-inflammation mechanism could attenuate cognitive impairment more effectively in ischemic rats, which may hold therapeutic potential in the clinical practice.
- Published
- 2021
- Full Text
- View/download PDF